In DCM, chronic defects in glucose and lipid metabolism result in OS, which blocks the activation of the PI3K/AKT signaling pathway, resulting in less intracellular glucose transport, which further impairs glucose and lipid metabolism. This evidence concerns the gene AKT1 and familial dilated cardiomyopathy.